Biomarker-guided de-escalation of empirical therapy is associated with lower risk for adverse outcomes

被引：0
|
作者：
Philipp Schuetz
Beat Mueller
机构：
[1] Kantonsspital Aarau,Medical University Department
来源：
Intensive Care Medicine | 2014年 / 40卷
关键词：
Antibiotic Therapy; Propensity Score; Intensive Care Unit Patient; Procalcitonin; Prospective Randomized Trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：141 / 141
相关论文
共 50 条
  • [21] The new frontiers of antiplatelet therapy: guided therapy and de-escalation after acute coronary syndrome or percutaneous coronary revascularization
    Gragnano, Felice
    Capolongo, Antonio
    Terracciano, Fabrizia
    Gargiulo, Giuseppe
    Cesaro, Arturo
    Moscarella, Elisabetta
    De Sio, Vincenzo
    Patti, Giuseppe
    Porto, Italo
    Esposito, Giovanni
    Calabro, Paolo
    GIORNALE ITALIANO DI CARDIOLOGIA, 2023, 24 (02) : 99 - 109
  • [22] Blood culture-guided de-escalation of empirical antimicrobial regimen for critical patients in an online antimicrobial stewardship programme
    Wang, Hsin-Yin
    Chiu, Cheng-Hsun
    Huang, Ching-Tai
    Cheng, Chun-Wen
    Lin, Yu-Jr
    Hsu, Ying-Jen
    Chen, Chi-Hua
    Deng, Shin-Tarng
    Leu, Hsieh-Shong
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2014, 44 (06) : 520 - 527
  • [23] De-Escalation of Multidisciplinary Breast Cancer Care with Cryoablation Therapy: Navigating Novel Therapeutics, Ethics, and Outcomes
    Cheng, Olivia
    Postlewait, Lauren M.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (03) : 1433 - 1435
  • [24] De-Escalation of Multidisciplinary Breast Cancer Care with Cryoablation Therapy: Navigating Novel Therapeutics, Ethics, and Outcomes
    Olivia Cheng
    Lauren M. Postlewait
    Annals of Surgical Oncology, 2024, 31 : 1433 - 1435
  • [25] De-escalation empirical antibiotic therapy improved survival for patients with severe aplastic anemia treated with antithymocyte globulin
    Fu, Rong
    Chen, Tong
    Song, Jia
    Wang, Guojin
    Li, Lijuan
    Ruan, Erbao
    Liu, Hui
    Wang, Yihao
    Wang, Huaquan
    Xing, Limin
    Wu, Yuhong
    Liu, Hong
    Qu, Wen
    Shao, Zonghong
    MEDICINE, 2017, 96 (06)
  • [26] Assessment of postoperative therapy de-escalation for early-stage, intermediate-risk cervical cancer
    Matsuo, Koji
    Shimada, Muneaki
    Matsuzaki, Shinya
    Machida, Hiroko
    Shigeta, Shogo
    Yoshida, Hiroshi
    Kato, Kazuyoshi
    Kanao, Hiroyuki
    Takekuma, Munetaka
    Mikami, Mikio
    Okamoto, Aiko
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (09) : 1349 - 1358
  • [27] De-escalation of biological therapy in Inflammatory bowel disease (IBD) and outcomes at week 52: a single centre experience
    Al-Talib, Ismaeel
    Iqbal, Majid
    Shaheen, Sirah
    Shingadia, Maya
    Slater, Jayne
    King, Dominic
    Rattehalli, Deepa
    De Silva, Shanika
    GUT, 2023, 72 (SUPPL_2) : A79 - A79
  • [28] De-escalation of Adjuvant Therapy in Operatively Managed HPV Associated Oropharyngeal Carcinoma: Current Status and Future Directions
    Ma, Daniel
    Routman, David M.
    SEMINARS IN RADIATION ONCOLOGY, 2025, 35 (02) : 166 - 172
  • [29] Impact of combination therapy and early de-escalation on outcome of ventilator-associated pneumonia caused by Pseudomonas aeruginosa
    Deconinck, Laurene
    Meybeck, Agnes
    Patoz, Pierre
    Van Grunderbeeck, Nicolas
    Boussekey, Nicolas
    Chiche, Arnaud
    Delannoy, Pierre-Yves
    Georges, Hugues
    Leroy, Olivier
    INFECTIOUS DISEASES, 2017, 49 (05) : 396 - 404
  • [30] Aggressive De-escalation in adjuvant Therapy for HPV-associated Oropharyngeal Cancer. Is Half of Everything enough?
    Hecht, Markus
    Semrau, Sabine
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (05) : 492 - 492
12345